Tirzepatide is a synthetic dual-receptor agonist studied for its interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways. Because these signaling systems are closely involved in metabolic regulation, Tirzepatide is widely investigated in research examining glucose homeostasis, insulin-related signaling, energy balance, nutrient utilization, and lipid metabolism.
In laboratory settings, Tirzepatide may be used to explore how coordinated GIP and GLP-1 receptor activity influences endocrine response, cellular signaling, appetite-related pathways, and broader metabolic processes. Its dual-receptor profile makes it a useful research compound for studying the relationship between incretin signaling and metabolic regulation.